REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Finmark Laboratories S.A (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Finmark Laboratories S.A Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Finmark Laboratories S A is primarily engaged in pharmaceutical and medicine manufacturing and related activities. It's been operating in the Colombian market since 2001.

Headquarters
Carrera 16 # 93 A - 36 Of. 204 - Edificio Business Center 93.
Bogota D.C.; Bogota D.C; Postal Code: 0814

Contact Details: Purchase the Finmark Laboratories S.A report to view the information.

Basic Information
Total Employees:
Purchase the Finmark Laboratories S.A report to view the information.
Outstanding Shares:
Purchase the Finmark Laboratories S.A report to view the information.
Incorporation Date:
March 16, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
38%
Purchase this report to view the information.
38%
Company Performance
Financial values in the chart are available after Finmark Laboratories S.A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
19.28%▲
Total operating revenue
19.49%▲
Operating profit (EBIT)
8.39%▲
EBITDA
19.36%▲
Net Profit (Loss) for the Period
4.63%▲
Total assets
-1.94%▼
Total equity
16.34%▲
Operating Profit Margin (ROS)
-1.87%▼
Net Profit Margin
-1.22%▼
Return on Equity (ROE)
-1.58%▼
Debt to Equity Ratio
-18.33%▼
Quick Ratio
0.1%▲
Cash Ratio
0.22%▲

Similar companies

Droguerias y Farmacias Cruz Verde S.A.S
 
Tecnoquimicas S.A.
Bayer S A
 
Procaps S.A.
Novartis de Colombia S A
 
Merck Sharp & Dohme Colombia S.A.S
Evolucia S.A.S.
 
Laboratorios Leon S.A. en Reorganizacion
Khemik S.A.S.
 
Biohealthy S.A.S.
Laboratorio Disnatura Nutricion Inteligente Sas
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo